Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Graduate Medical Education Committee Meetings 101.

Amedee RG, Guidroz D, Walker WT.

J Grad Med Educ. 2018 Dec;10(6):707-708. doi: 10.4300/JGME-D-18-00847.1. No abstract available.

PMID:
30619534
2.

Characterising the nutritional status of children with primary ciliary dyskinesia.

Marino LV, Harris A, Johnstone C, Friend A, Newell C, Miles EA, Lucas JS, Calder PC, Walker WT.

Clin Nutr. 2018 Sep 7. pii: S0261-5614(18)32428-2. doi: 10.1016/j.clnu.2018.08.034. [Epub ahead of print]

3.

NO way! Nasal nitric oxide measurement in infants.

Lucas JS, Walker WT.

Eur Respir J. 2018 Jun 21;51(6). pii: 1800958. doi: 10.1183/13993003.00958-2018. Print 2018 Jun. No abstract available.

PMID:
29929961
4.

Proceedings of the 2nd BEAT-PCD conference and 3rd PCD training school: part 1.

Halbeisen F, Hogg C, Alanin MC, Bukowy-Bieryllo Z, Dasi F, Duncan J, Friend A, Goutaki M, Jackson C, Keenan V, Harris A, Hirst RA, Latzin P, Marsh G, Nielsen K, Norris D, Pellicer D, Reula A, Rubbo B, Rumman N, Shoemark A, Walker WT, Kuehni CE, Lucas JS.

BMC Proc. 2018 Mar 5;12(Suppl 2):1. doi: 10.1186/s12919-018-0098-9. eCollection 2018.

5.

Exploring the Art of Ciliary Beating: The Benefits of High-Speed Video Analysis.

Lucas JS, Evans HJ, Haarman EG, Hirst RA, Hogg C, Jackson CL, Nielsen KG, Omran H, Papon JF, Robinson P, Shoemark A, Walker WT.

Chest. 2017 Dec;152(6):1348-1349. doi: 10.1016/j.chest.2017.06.053. No abstract available.

PMID:
29223261
6.

Primary ciliary dyskinesia ciliated airway cells show increased susceptibility to Haemophilus influenzae biofilm formation.

Walker WT, Jackson CL, Allan RN, Collins SA, Kelso MJ, Rineh A, Yepuri NR, Nicholas B, Lau L, Johnston D, Lackie P, Faust SN, Lucas JSA, Hall-Stoodley L.

Eur Respir J. 2017 Sep 10;50(3). pii: 1700612. doi: 10.1183/13993003.00612-2017. Print 2017 Sep.

7.

Clinical care of children with primary ciliary dyskinesia.

Lucas JS, Alanin MC, Collins S, Harris A, Johansen HK, Nielsen KG, Papon JF, Robinson P, Walker WT.

Expert Rev Respir Med. 2017 Oct;11(10):779-790. doi: 10.1080/17476348.2017.1360770. Epub 2017 Aug 2. Review.

PMID:
28745925
8.

Cephalosporin-3'-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms.

Collins SA, Kelso MJ, Rineh A, Yepuri NR, Coles J, Jackson CL, Halladay GD, Walker WT, Webb JS, Hall-Stoodley L, Connett GJ, Feelisch M, Faust SN, Lucas JS, Allan RN.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02086-16. doi: 10.1128/AAC.02086-16. Print 2017 Feb.

9.

European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia.

Lucas JS, Barbato A, Collins SA, Goutaki M, Behan L, Caudri D, Dell S, Eber E, Escudier E, Hirst RA, Hogg C, Jorissen M, Latzin P, Legendre M, Leigh MW, Midulla F, Nielsen KG, Omran H, Papon JF, Pohunek P, Redfern B, Rigau D, Rindlisbacher B, Santamaria F, Shoemark A, Snijders D, Tonia T, Titieni A, Walker WT, Werner C, Bush A, Kuehni CE.

Eur Respir J. 2017 Jan 4;49(1). pii: 1601090. doi: 10.1183/13993003.01090-2016. Print 2017 Jan.

10.

Morphological characteristics of subchondral bone cysts in medial femoral condyles of adult horses as determined by computed tomography.

Walker WT, Silverberg JL, Kawcak CE, Nelson BB, Fortier LA.

Am J Vet Res. 2016 Mar;77(3):265-74. doi: 10.2460/ajvr.77.3.265.

PMID:
26919597
11.

PICADAR: a diagnostic predictive tool for primary ciliary dyskinesia.

Behan L, Dimitrov BD, Kuehni CE, Hogg C, Carroll M, Evans HJ, Goutaki M, Harris A, Packham S, Walker WT, Lucas JS.

Eur Respir J. 2016 Apr;47(4):1103-12. doi: 10.1183/13993003.01551-2015. Epub 2016 Feb 25.

12.

Accuracy of diagnostic testing in primary ciliary dyskinesia.

Jackson CL, Behan L, Collins SA, Goggin PM, Adam EC, Coles JL, Evans HJ, Harris A, Lackie P, Packham S, Page A, Thompson J, Walker WT, Kuehni C, Lucas JS.

Eur Respir J. 2016 Mar;47(3):837-48. doi: 10.1183/13993003.00749-2015. Epub 2015 Dec 2.

13.

Neuronal NOS localises to human airway cilia.

Jackson CL, Lucas JS, Walker WT, Owen H, Premadeva I, Lackie PM.

Nitric Oxide. 2015 Jan 30;44:3-7. doi: 10.1016/j.niox.2014.11.003. Epub 2014 Nov 6.

PMID:
25460324
15.

Pulmonary radioaerosol mucociliary clearance in primary ciliary dyskinesia.

Walker WT, Young A, Bennett M, Guy M, Carroll M, Fleming J, Conway J, Lucas JS.

Eur Respir J. 2014 Aug;44(2):533-5. doi: 10.1183/09031936.00011814. Epub 2014 May 2. No abstract available.

16.

Diagnosis and management of primary ciliary dyskinesia.

Lucas JS, Burgess A, Mitchison HM, Moya E, Williamson M, Hogg C; National PCD Service, UK.

Arch Dis Child. 2014 Sep;99(9):850-6. doi: 10.1136/archdischild-2013-304831. Epub 2014 Apr 25. Review.

17.

Ciliated cultures from patients with primary ciliary dyskinesia produce nitric oxide in response to Haemophilus influenzae infection and proinflammatory cytokines.

Walker WT, Jackson CL, Coles J, Lackie PM, Faust SN, Hall-Stoodley L, Lucas JS.

Chest. 2014 Mar 1;145(3):668-669. doi: 10.1378/chest.13-2398. No abstract available.

PMID:
24590042
18.

Validation of a portable nitric oxide analyzer for screening in primary ciliary dyskinesias.

Harris A, Bhullar E, Gove K, Joslin R, Pelling J, Evans HJ, Walker WT, Lucas JS.

BMC Pulm Med. 2014 Feb 10;14:18. doi: 10.1186/1471-2466-14-18.

19.

Genetic Testing in the Diagnosis of Primary Ciliary Dyskinesia: State-of-the-Art and Future Perspectives.

Collins SA, Walker WT, Lucas JS.

J Clin Med. 2014 May 9;3(2):491-503. doi: 10.3390/jcm3020491. Review.

20.

Nasal nitric oxide is an important test in the diagnostic pathway for primary ciliary dyskinesia.

Lucas JS, Walker WT.

Ann Am Thorac Soc. 2013 Dec;10(6):645-7. doi: 10.1513/AnnalsATS.201309-328ED. No abstract available.

21.

Administration of AS03B-adjuvanted A(H1N1)pdm09 vaccine in children aged <3 years enhances antibody response to H3 and B viruses following a single dose of trivalent vaccine one year later.

Hoschler K, Andrews NJ, Faust SN, Finn A, Pollard AJ, Snape MD, Walker WT, Zambon M, Miller E.

Clin Infect Dis. 2014 Jan;58(2):181-7. doi: 10.1093/cid/cit692. Epub 2013 Oct 22.

PMID:
24149079
22.

Overcoming challenges in the management of primary ciliary dyskinesia: the UK model.

Lucas JS, Chetcuti P, Copeland F, Hogg C, Kenny T, Moya E, O'Callaghan C, Walker WT.

Paediatr Respir Rev. 2014 Jun;15(2):142-5. doi: 10.1016/j.prrv.2013.04.007. Epub 2013 Jun 12. Review.

PMID:
23764568
23.

Stroke in paediatric pneumococcal meningitis: a cross-sectional population-based study.

Pryde K, Walker WT, Hollingsworth C, Haywood P, Baird J, Hussey M, Freeman A, Gawne-Cain M, Harms B, Kirkham FJ, Faust SN.

Arch Dis Child. 2013 Aug;98(8):647-9. doi: 10.1136/archdischild-2013-304243. Epub 2013 Jun 11. No abstract available.

PMID:
23757479
24.

Medial femoral condyle morphometrics and subchondral bone density patterns in Thoroughbred racehorses.

Walker WT, Kawcak CE, Hill AE.

Am J Vet Res. 2013 May;74(5):691-9. doi: 10.2460/ajvr.74.5.691.

PMID:
23627381
25.

Upper and lower airway nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and asthma.

Walker WT, Liew A, Harris A, Cole J, Lucas JS.

Respir Med. 2013 Mar;107(3):380-6. doi: 10.1016/j.rmed.2012.11.021. Epub 2013 Jan 3.

26.

N-alkyldinaphthocarbazoles, azaheptacenes, for solution-processed organic field-effect transistors.

Pho TV, Yuen JD, Kurzman JA, Smith BG, Miao M, Walker WT, Seshadri R, Wudl F.

J Am Chem Soc. 2012 Nov 7;134(44):18185-8. doi: 10.1021/ja3082582. Epub 2012 Oct 26.

PMID:
23072644
27.

Nitric oxide in primary ciliary dyskinesia.

Walker WT, Jackson CL, Lackie PM, Hogg C, Lucas JS.

Eur Respir J. 2012 Oct;40(4):1024-32. Epub 2012 Mar 9. Review.

28.

H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study.

Walker WT, de Whalley P, Andrews N, Oeser C, Casey M, Michaelis L, Hoschler K, Harrill C, Moulsdale P, Thompson B, Jones C, Chalk J, Kerridge S, John TM, Okike I, Ladhani S, Tomlinson R, Heath PT, Miller E, Faust SN, Snape MD, Finn A, Pollard AJ.

Clin Infect Dis. 2012 Mar 1;54(5):661-9. doi: 10.1093/cid/cir905. Epub 2012 Jan 19.

29.

Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines.

Andrews NJ, Walker WT, Finn A, Heath PT, Collinson AC, Pollard AJ, Snape MD, Faust SN, Waight PA, Hoschler K, Sheasby L, Waddington C, Kerridge S, Chalk J, Reiner A, John T, Fletcher M, Allen R, Fineman N, Wilkins S, Casey M, Michaelis L, Oeser C, Okike I, Ladhani S, Miller E.

Vaccine. 2011 Oct 19;29(45):7913-9. doi: 10.1016/j.vaccine.2011.08.076. Epub 2011 Aug 27.

PMID:
21875635
30.

Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine.

Walker WT, Faust SN.

Expert Rev Vaccines. 2010 Dec;9(12):1385-98. doi: 10.1586/erv.10.141. Review.

PMID:
21105775
31.

Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age.

Waddington C, Andrews N, Hoschler K, Walker W, Oeser C, Reiner A, John T, Wilkins S, Casey M, Eccleston P, Allen R, Okike I, Ladhani S, Sheasby E, Waight P, Collinson A, Heath P, Finn A, Faust S, Snape M, Miller E, Pollard A.

Health Technol Assess. 2010 Oct;14(46):1-130. doi: 10.3310/hta14460-01.

32.

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.

Waddington CS, Walker WT, Oeser C, Reiner A, John T, Wilkins S, Casey M, Eccleston PE, Allen RJ, Okike I, Ladhani S, Sheasby E, Hoschler K, Andrews N, Waight P, Collinson AC, Heath PT, Finn A, Faust SN, Snape MD, Miller E, Pollard AJ.

BMJ. 2010 May 27;340:c2649. doi: 10.1136/bmj.c2649.

33.

Mechanism of cell death induced by cis-3, 4', 5-trimethoxy-3'-aminostilbene in ovarian cancer.

Durrant D, Richards JE, Walker WT, Baker KA, Simoni D, Lee RM.

Gynecol Oncol. 2008 Jul;110(1):110-7. doi: 10.1016/j.ygyno.2008.02.031. Epub 2008 Apr 22.

PMID:
18433847
34.

Quality of life after repair of tetralogy of Fallot.

Walker WT, Temple IK, Gnanapragasam JP, Goddard JR, Brown EM.

Cardiol Young. 2002 Dec;12(6):549-53.

PMID:
12636003
35.

Hyperpiesia; an analysis of one hundred cases treated personally.

WALKER WT.

Br Homeopath J. 1951 Apr;41(2):49-68. No abstract available.

PMID:
14858765
36.

Scrub typhus vaccine; its effect on 16 cases incubating the disease.

WALKER WT.

Br Med J. 1947 Apr 12;1(4501):484-7. No abstract available.

Supplemental Content

Loading ...
Support Center